• Phare
  • Validé par KD/KO

Anticorps Monoclonal anti-WWTR1/TAZ

WWTR1/TAZ Monoclonal Antibody for WB, IHC, IF-P, Indirect ELISA

Hôte / Isotype

Mouse / IgG1

Réactivité testée

Humain, rat, souris

Applications

WB, IHC, IF-P, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

2A12A10

N° de cat : 66500-1-PBS

Synonymes

TAZ, WWTR1, 2A12A10, Transcriptional coactivator with PDZ-binding motif, WW domain-containing transcription regulator protein 1



Informations sur le produit

66500-1-PBS cible WWTR1/TAZ dans les applications de WB, IHC, IF-P, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Hôte / Isotype Mouse / IgG1
Clonalité Monoclonal
Type Anticorps
Immunogène WWTR1/TAZ Protéine recombinante Ag13330
Nom complet WW domain containing transcription regulator 1
Masse moléculaire calculée 44 kDa
Poids moléculaire observé 55 kDa
Numéro d’acquisition GenBankBC014052
Symbole du gène WWTR1
Identification du gène (NCBI) 25937
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

TAZ, also referred as WWTR1, is a transcriptional co-activator with a PDZ-binding motif that is regulated by its interaction with 14-3-3 protein. TAZ is expressed in many primary tumors, such as breast cancer, thyroid carcinoma, colorectal cancer, and glioma. TAZ has been reported to be one of the nuclear effectors of Hippo-related pathways that regulate organ size control, cancer stem cell (CSC) properties, and epithelial-mesenchymal transition (EMT). TAZ has been defined for its role in the nucleus, where it functions directly as a transcriptional regulator by interacting with several nuclear factors as Runx2/Cbfa1, NHERF-2, TEF-1, TBX5, PAX3, PAX8 and TTF-1.

{{ptg:RelatedPrimaryAntibodies}}